Regadenoson Injection Market, Global Outlook and Forecast 2022-2028

May 2022 | 65 pages | ID: R87918AFAE6CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Regadenoson Injection in Global, including the following market information:

Global Regadenoson Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Regadenoson Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Regadenoson Injection include Astellas Pharma, Glenmark Pharmaceuticals, Gilead Sciences, Kingfriend and Heron Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Regadenoson Injection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Regadenoson Injection Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Regadenoson Injection Market Segment Percentages, by Type, 2021 (%)

• Original Drug
• Generic Drug

Global Regadenoson Injection Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Regadenoson Injection Market Segment Percentages, by Application, 2021 (%)

• Imaging Loading Drugs
• Disease Testing Agent
• Others

Global Regadenoson Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Regadenoson Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Regadenoson Injection revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Regadenoson Injection revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas Pharma
• Glenmark Pharmaceuticals
• Gilead Sciences
• Kingfriend
• Heron Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Regadenoson Injection Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Regadenoson Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL REGADENOSON INJECTION OVERALL MARKET SIZE

2.1 Global Regadenoson Injection Market Size: 2021 VS 2028
2.2 Global Regadenoson Injection Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Regadenoson Injection Players in Global Market
3.2 Top Global Regadenoson Injection Companies Ranked by Revenue
3.3 Global Regadenoson Injection Revenue by Companies
3.4 Top 3 and Top 5 Regadenoson Injection Companies in Global Market, by Revenue in 2021
3.5 Global Companies Regadenoson Injection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Regadenoson Injection Players in Global Market
  3.6.1 List of Global Tier 1 Regadenoson Injection Companies
  3.6.2 List of Global Tier 2 and Tier 3 Regadenoson Injection Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Regadenoson Injection Market Size Markets, 2021 & 2028
  4.1.2 Original Drug
  4.1.3 Generic Drug
4.2 By Type - Global Regadenoson Injection Revenue & Forecasts
  4.2.1 By Type - Global Regadenoson Injection Revenue, 2017-2022
  4.2.2 By Type - Global Regadenoson Injection Revenue, 2023-2028
  4.2.3 By Type - Global Regadenoson Injection Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Regadenoson Injection Market Size, 2021 & 2028
  5.1.2 Imaging Loading Drugs
  5.1.3 Disease Testing Agent
  5.1.4 Others
5.2 By Application - Global Regadenoson Injection Revenue & Forecasts
  5.2.1 By Application - Global Regadenoson Injection Revenue, 2017-2022
  5.2.2 By Application - Global Regadenoson Injection Revenue, 2023-2028
  5.2.3 By Application - Global Regadenoson Injection Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Regadenoson Injection Market Size, 2021 & 2028
6.2 By Region - Global Regadenoson Injection Revenue & Forecasts
  6.2.1 By Region - Global Regadenoson Injection Revenue, 2017-2022
  6.2.2 By Region - Global Regadenoson Injection Revenue, 2023-2028
  6.2.3 By Region - Global Regadenoson Injection Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Regadenoson Injection Revenue, 2017-2028
  6.3.2 US Regadenoson Injection Market Size, 2017-2028
  6.3.3 Canada Regadenoson Injection Market Size, 2017-2028
  6.3.4 Mexico Regadenoson Injection Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Regadenoson Injection Revenue, 2017-2028
  6.4.2 Germany Regadenoson Injection Market Size, 2017-2028
  6.4.3 France Regadenoson Injection Market Size, 2017-2028
  6.4.4 U.K. Regadenoson Injection Market Size, 2017-2028
  6.4.5 Italy Regadenoson Injection Market Size, 2017-2028
  6.4.6 Russia Regadenoson Injection Market Size, 2017-2028
  6.4.7 Nordic Countries Regadenoson Injection Market Size, 2017-2028
  6.4.8 Benelux Regadenoson Injection Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Regadenoson Injection Revenue, 2017-2028
  6.5.2 China Regadenoson Injection Market Size, 2017-2028
  6.5.3 Japan Regadenoson Injection Market Size, 2017-2028
  6.5.4 South Korea Regadenoson Injection Market Size, 2017-2028
  6.5.5 Southeast Asia Regadenoson Injection Market Size, 2017-2028
  6.5.6 India Regadenoson Injection Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Regadenoson Injection Revenue, 2017-2028
  6.6.2 Brazil Regadenoson Injection Market Size, 2017-2028
  6.6.3 Argentina Regadenoson Injection Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Regadenoson Injection Revenue, 2017-2028
  6.7.2 Turkey Regadenoson Injection Market Size, 2017-2028
  6.7.3 Israel Regadenoson Injection Market Size, 2017-2028
  6.7.4 Saudi Arabia Regadenoson Injection Market Size, 2017-2028
  6.7.5 UAE Regadenoson Injection Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astellas Pharma
  7.1.1 Astellas Pharma Corporate Summary
  7.1.2 Astellas Pharma Business Overview
  7.1.3 Astellas Pharma Regadenoson Injection Major Product Offerings
  7.1.4 Astellas Pharma Regadenoson Injection Revenue in Global Market (2017-2022)
  7.1.5 Astellas Pharma Key News
7.2 Glenmark Pharmaceuticals
  7.2.1 Glenmark Pharmaceuticals Corporate Summary
  7.2.2 Glenmark Pharmaceuticals Business Overview
  7.2.3 Glenmark Pharmaceuticals Regadenoson Injection Major Product Offerings
  7.2.4 Glenmark Pharmaceuticals Regadenoson Injection Revenue in Global Market (2017-2022)
  7.2.5 Glenmark Pharmaceuticals Key News
7.3 Gilead Sciences
  7.3.1 Gilead Sciences Corporate Summary
  7.3.2 Gilead Sciences Business Overview
  7.3.3 Gilead Sciences Regadenoson Injection Major Product Offerings
  7.3.4 Gilead Sciences Regadenoson Injection Revenue in Global Market (2017-2022)
  7.3.5 Gilead Sciences Key News
7.4 Kingfriend
  7.4.1 Kingfriend Corporate Summary
  7.4.2 Kingfriend Business Overview
  7.4.3 Kingfriend Regadenoson Injection Major Product Offerings
  7.4.4 Kingfriend Regadenoson Injection Revenue in Global Market (2017-2022)
  7.4.5 Kingfriend Key News
7.5 Heron Pharma
  7.5.1 Heron Pharma Corporate Summary
  7.5.2 Heron Pharma Business Overview
  7.5.3 Heron Pharma Regadenoson Injection Major Product Offerings
  7.5.4 Heron Pharma Regadenoson Injection Revenue in Global Market (2017-2022)
  7.5.5 Heron Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Regadenoson Injection Market Opportunities & Trends in Global Market
Table 2. Regadenoson Injection Market Drivers in Global Market
Table 3. Regadenoson Injection Market Restraints in Global Market
Table 4. Key Players of Regadenoson Injection in Global Market
Table 5. Top Regadenoson Injection Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Regadenoson Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Regadenoson Injection Revenue Share by Companies, 2017-2022
Table 8. Global Companies Regadenoson Injection Product Type
Table 9. List of Global Tier 1 Regadenoson Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Regadenoson Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Regadenoson Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Regadenoson Injection Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Regadenoson Injection Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Regadenoson Injection Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Regadenoson Injection Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Regadenoson Injection Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Regadenoson Injection Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Regadenoson Injection Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Regadenoson Injection Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Regadenoson Injection Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Regadenoson Injection Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Regadenoson Injection Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Regadenoson Injection Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Regadenoson Injection Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Regadenoson Injection Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Regadenoson Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Regadenoson Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Regadenoson Injection Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Regadenoson Injection Revenue, (US$, Mn), 2023-2028
Table 30. Astellas Pharma Corporate Summary
Table 31. Astellas Pharma Regadenoson Injection Product Offerings
Table 32. Astellas Pharma Regadenoson Injection Revenue (US$, Mn), (2017-2022)
Table 33. Glenmark Pharmaceuticals Corporate Summary
Table 34. Glenmark Pharmaceuticals Regadenoson Injection Product Offerings
Table 35. Glenmark Pharmaceuticals Regadenoson Injection Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Regadenoson Injection Product Offerings
Table 38. Gilead Sciences Regadenoson Injection Revenue (US$, Mn), (2017-2022)
Table 39. Kingfriend Corporate Summary
Table 40. Kingfriend Regadenoson Injection Product Offerings
Table 41. Kingfriend Regadenoson Injection Revenue (US$, Mn), (2017-2022)
Table 42. Heron Pharma Corporate Summary
Table 43. Heron Pharma Regadenoson Injection Product Offerings
Table 44. Heron Pharma Regadenoson Injection Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Regadenoson Injection Segment by Type in 2021
Figure 2. Regadenoson Injection Segment by Application in 2021
Figure 3. Global Regadenoson Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Regadenoson Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Regadenoson Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Regadenoson Injection Revenue in 2021
Figure 8. By Type - Global Regadenoson Injection Revenue Market Share, 2017-2028
Figure 9. By Application - Global Regadenoson Injection Revenue Market Share, 2017-2028
Figure 10. By Region - Global Regadenoson Injection Revenue Market Share, 2017-2028
Figure 11. By Country - North America Regadenoson Injection Revenue Market Share, 2017-2028
Figure 12. US Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Regadenoson Injection Revenue Market Share, 2017-2028
Figure 16. Germany Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 17. France Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Regadenoson Injection Revenue Market Share, 2017-2028
Figure 24. China Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 28. India Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Regadenoson Injection Revenue Market Share, 2017-2028
Figure 30. Brazil Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Regadenoson Injection Revenue Market Share, 2017-2028
Figure 33. Turkey Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Regadenoson Injection Revenue, (US$, Mn), 2017-2028
Figure 37. Astellas Pharma Regadenoson Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Glenmark Pharmaceuticals Regadenoson Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Regadenoson Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kingfriend Regadenoson Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Heron Pharma Regadenoson Injection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)